Arkolith/Insider Trading/ZSAN/Form 4

Lo Steven

Chief Executive Officer, DirectorZosano Pharma Corp (ZSAN) · full profile →Form 4 · filed Oct 19, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2021Grant(A)119K—$0484K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2021Grant(A)238K—$0238K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-21-018472) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML